Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/19/11 → 8/30/14 |
101MS326: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects with Secondary Progressive Multiple Sclerosis
- Berger, Joseph (PI)